{"entity":{"type":"insider","cik":"0001957180","url":"/insider/0001957180","json_url":"/insider/0001957180.json","name":"Milanova Tsveta","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2023-06-30","last":"2026-04-06","span_basis":"filed_date"},"name_variants":[{"name":"Milanova Tsveta","source":"filing","n_filings":10,"first_seen":"2023-06-30","last_seen":"2026-04-06"}],"transactions":[{"id":5871106,"accession":"0001439222-26-000061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-26-000061","line_url":"/filing/0001439222-26-000061#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001957180","owner_name":"Milanova Tsveta","owner_display_name":"Milanova Tsveta","owner_url":"/insider/0001957180","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3262.0,"shares_display":"3,262","price_per_share":34.71,"price_display":"34.71","price_state":"stated","total_value":113224.02,"total_display":"113,224.02","total_whole":"113,224","shares_owned_after":46829.0,"shares_owned_after_display":"46,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-06","scope":"insider"},{"id":5765434,"accession":"0001439222-26-000036","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-26-000036","line_url":"/filing/0001439222-26-000036","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001957180","owner_name":"Milanova Tsveta","owner_display_name":"Milanova Tsveta","owner_url":"/insider/0001957180","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2868.0,"shares_display":"2,868","price_per_share":28.96,"price_display":"28.96","price_state":"stated","total_value":83057.28,"total_display":"83,057.28","total_whole":"83,057","shares_owned_after":38778.0,"shares_owned_after_display":"38,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider","n_lines":2},{"id":5783767,"accession":"0001439222-26-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-26-000013","line_url":"/filing/0001439222-26-000013#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001957180","owner_name":"Milanova Tsveta","owner_display_name":"Milanova Tsveta","owner_url":"/insider/0001957180","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2872.0,"shares_display":"2,872","price_per_share":27.02,"price_display":"27.02","price_state":"stated","total_value":77601.44,"total_display":"77,601.44","total_whole":"77,601","shares_owned_after":34793.0,"shares_owned_after_display":"34,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":6147953,"accession":"0001439222-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-26-000004","line_url":"/filing/0001439222-26-000004#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001957180","owner_name":"Milanova Tsveta","owner_display_name":"Milanova Tsveta","owner_url":"/insider/0001957180","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2932.0,"shares_display":"2,932","price_per_share":27.09,"price_display":"27.09","price_state":"stated","total_value":79427.88,"total_display":"79,427.88","total_whole":"79,428","shares_owned_after":29190.0,"shares_owned_after_display":"29,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-30","filed_date":"2026-01-02","scope":"insider"},{"id":5011755,"accession":"0001439222-25-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000065","line_url":"/filing/0001439222-25-000065#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001957180","owner_name":"Milanova Tsveta","owner_display_name":"Milanova Tsveta","owner_url":"/insider/0001957180","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2770.0,"shares_display":"2,770","price_per_share":33.54,"price_display":"33.54","price_state":"stated","total_value":92905.8,"total_display":"92,905.80","total_whole":"92,906","shares_owned_after":26122.0,"shares_owned_after_display":"26,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-26","scope":"insider"},{"id":4119293,"accession":"0001439222-25-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000017","line_url":"/filing/0001439222-25-000017#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001957180","owner_name":"Milanova Tsveta","owner_display_name":"Milanova Tsveta","owner_url":"/insider/0001957180","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1681.0,"shares_display":"1,681","price_per_share":35.54,"price_display":"35.54","price_state":"stated","total_value":59742.74,"total_display":"59,742.74","total_whole":"59,743","shares_owned_after":22892.0,"shares_owned_after_display":"22,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":4435876,"accession":"0001439222-25-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000002","line_url":"/filing/0001439222-25-000002#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001957180","owner_name":"Milanova Tsveta","owner_display_name":"Milanova Tsveta","owner_url":"/insider/0001957180","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2804.0,"shares_display":"2,804","price_per_share":32.18,"price_display":"32.18","price_state":"stated","total_value":90232.72,"total_display":"90,232.72","total_whole":"90,233","shares_owned_after":18906.0,"shares_owned_after_display":"18,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":2607014,"accession":"0001439222-24-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000012","line_url":"/filing/0001439222-24-000012#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001957180","owner_name":"Milanova Tsveta","owner_display_name":"Milanova Tsveta","owner_url":"/insider/0001957180","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1618.0,"shares_display":"1,618","price_per_share":21.64,"price_display":"21.64","price_state":"stated","total_value":35013.52,"total_display":"35,013.52","total_whole":"35,014","shares_owned_after":13234.0,"shares_owned_after_display":"13,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-24","scope":"insider"},{"id":2911387,"accession":"0001439222-24-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000002","line_url":"/filing/0001439222-24-000002#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001957180","owner_name":"Milanova Tsveta","owner_display_name":"Milanova Tsveta","owner_url":"/insider/0001957180","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2902.0,"shares_display":"2,902","price_per_share":22.32,"price_display":"22.32","price_state":"stated","total_value":64772.64,"total_display":"64,772.64","total_whole":"64,773","shares_owned_after":9404.0,"shares_owned_after_display":"9,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-05","scope":"insider"},{"id":8733740,"accession":"0001439222-23-000099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000099","line_url":"/filing/0001439222-23-000099#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001957180","owner_name":"Milanova Tsveta","owner_display_name":"Milanova Tsveta","owner_url":"/insider/0001957180","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1618.0,"shares_display":"1,618","price_per_share":28.36,"price_display":"28.36","price_state":"stated","total_value":45886.48,"total_display":"45,886.48","total_whole":"45,886","shares_owned_after":3831.0,"shares_owned_after_display":"3,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-06-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Officer (Chief Commercial Officer)","n_filings":10,"first_seen":"2023-06-30","last_seen":"2026-04-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001957180","retrieved_at":"2026-08-26T01:47:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}